- Home
- CABA vs AVD Comparison
CABA vs AVD Comparison
Compare CABA & AVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CABA
- AVD
- Stock Information
- Founded
- CABA 2017
- AVD 1969
- Country
- CABA United States
- AVD United States
- Employees
- CABA N/A
- AVD N/A
- Industry
- CABA Biotechnology: Biological Products (No Diagnostic Substances)
- AVD Agricultural Chemicals
- Sector
- CABA Health Care
- AVD Industrials
- Exchange
- CABA Nasdaq
- AVD Nasdaq
- Market Cap
- CABA 118.8M
- AVD 135.6M
- IPO Year
- CABA 2019
- AVD N/A
- Fundamental
- Price
- CABA $1.55
- AVD $4.43
- Analyst Decision
- CABA Strong Buy
- AVD Strong Buy
- Analyst Count
- CABA 8
- AVD 2
- Target Price
- CABA $26.13
- AVD $17.00
- AVG Volume (30 Days)
- CABA 801.5K
- AVD 278.2K
- Earning Date
- CABA 05-14-2025
- AVD 03-14-2025
- Dividend Yield
- CABA N/A
- AVD 0.68%
- EPS Growth
- CABA N/A
- AVD N/A
- EPS
- CABA N/A
- AVD N/A
- Revenue
- CABA N/A
- AVD $553,839,000.00
- Revenue This Year
- CABA $101.54
- AVD N/A
- Revenue Next Year
- CABA N/A
- AVD $5.98
- P/E Ratio
- CABA N/A
- AVD N/A
- Revenue Growth
- CABA N/A
- AVD N/A
- 52 Week Low
- CABA $1.45
- AVD $4.20
- 52 Week High
- CABA $19.04
- AVD $13.13
- Technical
- Relative Strength Index (RSI)
- CABA 34.36
- AVD 42.05
- Support Level
- CABA $1.45
- AVD $4.20
- Resistance Level
- CABA $1.85
- AVD $4.74
- Average True Range (ATR)
- CABA 0.14
- AVD 0.28
- MACD
- CABA -0.00
- AVD 0.00
- Stochastic Oscillator
- CABA 17.86
- AVD 27.38
About CABA Cabaletta Bio Inc.
Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies, and exploring their potential to provide a deep and durable, perhaps curative, treatment, for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) has the potential to be applied across a broad range of autoimmune diseases.
About AVD American Vanguard Corporation ($0.10 Par Value)
American Vanguard Corp is a United States-based diversified specialty and agricultural products company. It manufactures and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.